New research data revealed that virtual fertility testing using remote ultrasonography gives quality clinical imaging and antral follicle counts to better guide the reproductive management decisions
Clarius Mobile Health and Turtle Health have joined forces to introduce virtual transvaginal ultrasonography solution. (Credit: PRNewswire/ Clarius Mobile Health)
Canada-based Clarius Mobile Health and virtual gynaecology clinic Turtle Health have joined forces to launch a virtual transvaginal ultrasonography solution in the market.
The device is claimed to bring the convenience of at-home testing to women.
Turtle Health’s at-home testing solution includes a Clarius EC7 HD handheld wireless ultrasound scanner that works with the Clarius Ultrasound App on a smartphone.
A technician uses Clarius Live telemedicine to connect with the user and provide real-time instruction for collecting clinical-quality images, which are then submitted for analysis.
Clarius Mobile Health president Ohad Arazi said: “We’re delighted to see the results of this research showing the efficacy of using Clarius ultrasound to empower virtual women’s health.
“Our easy-to-use wireless endocavity scanner, combined with the power of artificial intelligence, connection to the cloud, and one-touch telemedicine, offers a unique solution for patient engagement.”
Arazi added: “At Clarius, we’re working with partners to deliver highly specialized ultrasound imaging solutions to market.
“Today, we’re pleased to announce our partnership with Turtle Health as we work together to fuel their mission to make gynaecological care virtual and unlock access to affordable, patient-enabled ultrasound imaging.”
According to a study funded by Turtle Health and published in the April 2022 edition of the Journal of Obstetrics and Gynecology, self-administered transvaginal ultrasound exams guided remotely by a trained technologist are similar to in-clinic ultrasonography.
They produce clinical-quality images and assess antral follicle count to estimate ovarian reserve and evaluate women’s reproductive potential.
Turtle Health co-founder and CEO Amy Zwanziger said: “Women have a fundamental right to information about their bodies, and we founded Turtle Health to empower women to access information when they need and want it, from the convenience and privacy of home.
“We are delighted that new data support clear at-home visualisation of the uterus and ovaries in a diverse range of women, which can be used for a variety of gynaecological applications.”